AMY SCHLEIFER: Open Payments
NPI 1194784363 · MT PLEASANT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 46 payments from 11 companies in 2025. Trend: 2023 $651 · 2024 $837 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $277 |
| AstraZeneca Pharmaceuticals LP | 7 | $192 |
| Abbott Laboratories | 3 | $142 |
| Lilly USA, LLC | 5 | $96 |
| ABBVIE INC. | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Exact Sciences Corporation | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| PFIZER INC. | 1 | $19 |
Products named: PROCLAIM, AIRSUPRA, Ozempic, FARXIGA, JARDIANCE, Wegovy, Rybelsus, Kerendia.
Industry payments across PA — which companies pay providers there.
